Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma
Open Access
- 11 May 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Gastroenterology
- Vol. 9 (1), 31
- https://doi.org/10.1186/1471-230x-9-31
Abstract
Percutaneous radiofrequency ablation (RFA) has gained popularity in the treatment of hepatocellular carcinoma (HCC). However, its role versus other conventional minimally invasive therapies is still a matter of debate. The purpose of this work is to analyse the efficacy and safety of RFA versus that of ethanol injection (PEI), the percutaneous standard approach to treat nonsurgical HCC.Keywords
This publication has 45 references indexed in Scilit:
- Thermal ablation of hepatocellular carcinomaCancer Imaging, 2008
- Influence of operator experience in radiofrequency ablation of malignant liver tumours on treatment outcomeEuropean Journal of Surgical Oncology, 2006
- Radiofrequency Ablation of Liver TumorsArchives of Surgery, 2006
- Percutaneous ethanol injection for small hepatocellular carcinoma: Therapeutic efficacy based on 20-year observationJournal of Hepatology, 2005
- Updated treatment approach to hepatocellular carcinomaThe Esophagus, 2005
- Measuring inconsistency in meta-analysesBMJ, 2003
- Interstitial ablative techniques for hepatic tumoursBritish Journal of Surgery, 2003
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Radiofrequency tumor ablation: principles and techniquesEuropean Journal of Ultrasound, 2001
- Locoregional treatments for hepatocellular carcinomaBest Practice & Research Clinical Gastroenterology, 1999